Gemtuzumab for relapsed acute myeloid leukemia

MeSH terms

• Acute Disease
• Aged
• Aminoglycosides*
• Anti-Bacterial Agents / adverse effects
• Anti-Bacterial Agents / therapeutic use*
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Costs and Cost Analysis
• Diphenhydramine / therapeutic use
• Gemtuzumab
• Humans
• Immunotoxins / adverse effects
• Immunotoxins / therapeutic use
• Infusions, Intravenous / economics
• Leukemia, Myeloid / drug therapy*
• Middle Aged
• Premedication